- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.5: 7 residues within 4Å:- Chain A: S.429, L.430, N.433, P.551, Q.608, D.609
- Ligands: EDO.16
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.609
NAG-NAG-BMA.27: 7 residues within 4Å:- Chain B: S.429, L.430, N.433, P.551, Q.608, D.609
- Ligands: EDO.38
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.609
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.6: 10 residues within 4Å:- Chain A: S.588, S.591, A.592, N.595, Q.697
- Chain B: L.67, H.69, E.233, Y.234, R.311
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.233, B:R.311, B:R.311, B:H.69
- Water bridges: B:H.69, B:E.66
NAG-NAG-BMA-MAN-MAN.28: 10 residues within 4Å:- Chain A: L.67, H.69, E.233, Y.234, R.311
- Chain B: S.588, S.591, A.592, N.595, Q.697
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.233, A:R.311, A:R.311, A:H.69
- Water bridges: A:H.69, A:E.66
- 4 x ZN: ZINC ION(Non-covalent)
ZN.7: 5 residues within 4Å:- Chain A: D.344, E.382, H.510
- Ligands: ZN.8, FVW.22
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.344, A:E.382, A:E.382, A:H.510, H2O.10
ZN.8: 6 residues within 4Å:- Chain A: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.7
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.334, A:D.344, A:D.410, A:D.410, H2O.10
ZN.29: 5 residues within 4Å:- Chain B: D.344, E.382, H.510
- Ligands: ZN.30, FVW.44
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.344, B:E.382, B:E.382, B:H.510, H2O.31
ZN.30: 6 residues within 4Å:- Chain B: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.29
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.334, B:D.344, B:D.410, B:D.410, H2O.31
- 2 x CA: CALCIUM ION(Non-covalent)
CA.9: 4 residues within 4Å:- Chain A: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:T.226, A:Y.229, A:E.390, A:E.390, A:E.393
CA.31: 4 residues within 4Å:- Chain B: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:T.226, B:Y.229, B:E.390, B:E.390, B:E.393
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.12: 4 residues within 4Å:- Chain A: E.701, E.705
- Chain B: W.391, L.398
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:Y.328, A:E.701
- Water bridges: A:S.704
PEG.20: 3 residues within 4Å:- Chain A: K.29, Y.32, Y.516
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Y.516
PEG.21: 6 residues within 4Å:- Chain A: R.555, A.558, V.559, R.562, V.593, T.597
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:A.558
PEG.34: 4 residues within 4Å:- Chain A: W.391, L.398
- Chain B: E.701, E.705
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:E.701, A:Y.328
- Water bridges: B:S.704
PEG.42: 3 residues within 4Å:- Chain B: K.29, Y.32, Y.516
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Y.516
PEG.43: 6 residues within 4Å:- Chain B: R.555, A.558, V.559, R.562, V.593, T.597
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:A.558
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.13: 2 residues within 4Å:- Chain A: R.238
- Chain B: R.687
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:R.238
- Water bridges: B:R.687, B:R.687
EDO.14: 3 residues within 4Å:- Chain A: G.42, Y.76, K.79
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:G.42, A:K.79, A:K.79
EDO.15: 4 residues within 4Å:- Chain A: S.470, K.471, A.658, G.659
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:K.471, A:K.471, A:G.659
- Water bridges: A:S.470, A:K.471
EDO.16: 5 residues within 4Å:- Chain A: V.549, L.550, P.551, F.552
- Ligands: NAG-NAG-BMA.5
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.547, A:S.547, A:F.552
EDO.17: 3 residues within 4Å:- Chain A: E.598, I.599, K.602
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.602, A:K.602
- Water bridges: A:N.595
EDO.18: 5 residues within 4Å:- Chain A: R.555, S.601, S.604, E.605, Q.608
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.555, A:S.601, A:Q.608
EDO.35: 2 residues within 4Å:- Chain A: R.687
- Chain B: R.238
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:R.238
- Water bridges: A:R.687, A:R.687
EDO.36: 3 residues within 4Å:- Chain B: G.42, Y.76, K.79
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:G.42, B:K.79, B:K.79
EDO.37: 4 residues within 4Å:- Chain B: S.470, K.471, A.658, G.659
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:K.471, B:K.471, B:G.659
- Water bridges: B:S.470, B:K.471
EDO.38: 5 residues within 4Å:- Chain B: V.549, L.550, P.551, F.552
- Ligands: NAG-NAG-BMA.27
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.547, B:S.547, B:F.552
EDO.39: 3 residues within 4Å:- Chain B: E.598, I.599, K.602
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:K.602, B:K.602
- Water bridges: B:N.595
EDO.40: 5 residues within 4Å:- Chain B: R.555, S.601, S.604, E.605, Q.608
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.555, B:S.601, B:Q.608
- 2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 2 x FVW: (2~{S})-2-[[(2~{S})-6-[(6-fluoranylpyridin-3-yl)-methyl-amino]-1-oxidanyl-1,6-bis(oxidanylidene)hexan-2-yl]carbamoylamino]pentanedioic acid(Non-covalent)
FVW.22: 24 residues within 4Å:- Chain A: G.163, K.164, V.165, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, E.414, G.475, N.476, R.491, R.493, W.498, S.504, G.505, Y.509, H.510, K.656, Y.657
- Ligands: ZN.7
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:Y.509, A:Y.657, A:Y.657
- Hydrogen bonds: A:N.214, A:R.420, A:G.475, A:G.475, A:N.476, A:R.493, A:Y.509
- Water bridges: A:Q.211, A:N.214, A:D.344, A:R.491, A:K.656
- Salt bridges: A:R.167, A:R.491, A:R.493, A:H.510, A:K.656
FVW.44: 24 residues within 4Å:- Chain B: G.163, K.164, V.165, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, E.414, G.475, N.476, R.491, R.493, W.498, S.504, G.505, Y.509, H.510, K.656, Y.657
- Ligands: ZN.29
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:Y.509, B:Y.657, B:Y.657
- Hydrogen bonds: B:N.214, B:R.420, B:G.475, B:G.475, B:N.476, B:R.493, B:Y.509
- Water bridges: B:Q.211, B:N.214, B:D.344, B:R.491, B:K.656
- Salt bridges: B:R.167, B:R.491, B:R.493, B:H.510, B:K.656
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakajima, R. et al., 2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics. ACS Med Chem Lett (2018)
- Release Date
- 2018-12-05
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 2 x FVW: (2~{S})-2-[[(2~{S})-6-[(6-fluoranylpyridin-3-yl)-methyl-amino]-1-oxidanyl-1,6-bis(oxidanylidene)hexan-2-yl]carbamoylamino]pentanedioic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakajima, R. et al., 2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics. ACS Med Chem Lett (2018)
- Release Date
- 2018-12-05
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A